|The Gentamycin n/a (Catalog #MBS615263) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Gentamycin can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Radioimmunoassay (RIA).
Suitable for use in ELISA and RIA. Researchers should empirically determine the suitability of the Gentamycin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Gentamycin n/a product has the following accession number(s) (GI #8346635) (NCBI Accession #CAB93900.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Broad spectrum, cell culture antibiotic that is non toxic to viruses and mammalian cells at antibacterial levels. Inhibits growth of gram positive and negative bacteria and mycoplasma. Inhibits normal protein synthesis by binding to L6 protein of 50S ribosomal subunit. Useful antibiotic for Baculovirus expression systems since mutations in rplF prevent Gentamycin from binding.
Immunogen: Gentamicin (KLH). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Gentamycin are readily searchable from our website. Different antibodies against the same target such as Gentamycin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.